<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>Pharma Watchdog</title>
	<atom:link href="http://pharmawatchdog.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmawatchdog.wordpress.com</link>
	<description>Keeping an Eye on the Pharmaceutical Industry and the FDA</description>
	<lastBuildDate>Tue, 31 Jan 2012 22:11:34 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='pharmawatchdog.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title>Pharma Watchdog</title>
		<link>http://pharmawatchdog.wordpress.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://pharmawatchdog.wordpress.com/osd.xml" title="Pharma Watchdog" />
	<atom:link rel='hub' href='http://pharmawatchdog.wordpress.com/?pushpress=hub'/>
		<item>
		<title>New FDA Supplemental Guidelines Has Booming Industry Upset</title>
		<link>http://pharmawatchdog.wordpress.com/2012/01/31/new-fda-supplemental-guidelines-has-booming-industry-upset/</link>
		<comments>http://pharmawatchdog.wordpress.com/2012/01/31/new-fda-supplemental-guidelines-has-booming-industry-upset/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 22:00:07 +0000</pubDate>
		<dc:creator>Sadaka Associates</dc:creator>
				<category><![CDATA[Drug Safety News]]></category>
		<category><![CDATA[Amino Acids]]></category>
		<category><![CDATA[Dietary Supplements]]></category>
		<category><![CDATA[Herbal Ingredients]]></category>
		<category><![CDATA[Minerals]]></category>
		<category><![CDATA[New Guidelines]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[Vitamins]]></category>

		<guid isPermaLink="false">http://pharmawatchdog.wordpress.com/?p=642</guid>
		<description><![CDATA[A new proposal to toughen the Food and Drug Administration&#8217;s power to regulate dietary supplements has the makers of vitamins, minerals and botanical extracts in an uproar.  They are mad and upset at the new guidelines and believe that they are too strong.  But other’s simply don’t agree.  One editorial found in the New England [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=pharmawatchdog.wordpress.com&amp;blog=1601809&amp;post=642&amp;subd=pharmawatchdog&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://pharmawatchdog.wordpress.com/2012/01/31/new-fda-supplemental-guidelines-has-booming-industry-upset/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7890ac322015a6ecd7b4497043175751?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Potts Sadaka LLC</media:title>
		</media:content>
	</item>
		<item>
		<title>Deaths Reported After Doctors Ignored Kenalog Warning &amp; FDA Failed To Adequately Warn</title>
		<link>http://pharmawatchdog.wordpress.com/2012/01/31/deaths-reported-after-doctors-ignored-kenalog-warning-fda-failed-to-adequately-warn/</link>
		<comments>http://pharmawatchdog.wordpress.com/2012/01/31/deaths-reported-after-doctors-ignored-kenalog-warning-fda-failed-to-adequately-warn/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 13:00:34 +0000</pubDate>
		<dc:creator>Sadaka Associates</dc:creator>
				<category><![CDATA[Drug Safety News]]></category>
		<category><![CDATA[Adverse Medical Events]]></category>
		<category><![CDATA[Bristol-Myers Squibb Co]]></category>
		<category><![CDATA[Death]]></category>
		<category><![CDATA[Epidural Injection]]></category>
		<category><![CDATA[Steroid Injection]]></category>

		<guid isPermaLink="false">http://pharmawatchdog.wordpress.com/?p=638</guid>
		<description><![CDATA[Seven months ago Bristol-Myers Squibb issued a public safety alert and changed the label of the Kenalog injection to indicate that use of it in epidurals had been linked with “serious medical events, including death” and that use of it as an epidural injection was “not recommended.” But according to reports Doctors are still injecting [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=pharmawatchdog.wordpress.com&amp;blog=1601809&amp;post=638&amp;subd=pharmawatchdog&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://pharmawatchdog.wordpress.com/2012/01/31/deaths-reported-after-doctors-ignored-kenalog-warning-fda-failed-to-adequately-warn/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7890ac322015a6ecd7b4497043175751?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Potts Sadaka LLC</media:title>
		</media:content>
	</item>
		<item>
		<title>FDA Finally Addresses Social Networking Issue &amp; Gives Guidelines On How To Interact With Consumers</title>
		<link>http://pharmawatchdog.wordpress.com/2012/01/30/fda-finally-addresses-social-networking-issue-gives-guidelines-on-how-to-interact-with-consumers/</link>
		<comments>http://pharmawatchdog.wordpress.com/2012/01/30/fda-finally-addresses-social-networking-issue-gives-guidelines-on-how-to-interact-with-consumers/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 22:00:17 +0000</pubDate>
		<dc:creator>Sadaka Associates</dc:creator>
				<category><![CDATA[Drug Safety News]]></category>
		<category><![CDATA[Facebook]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[Rules]]></category>
		<category><![CDATA[Social Network]]></category>
		<category><![CDATA[Twitter]]></category>
		<category><![CDATA[YouTube]]></category>

		<guid isPermaLink="false">http://pharmawatchdog.wordpress.com/?p=635</guid>
		<description><![CDATA[The FDA is issuing new rules to pharmaceutical companies regarding how they are to interact with consumers on social media. The rules will not yet have an impact though as companies say they need more clarification from the FDA before they’re comfortable getting back online again, according to The American Medical Association (AMA). The agency’s [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=pharmawatchdog.wordpress.com&amp;blog=1601809&amp;post=635&amp;subd=pharmawatchdog&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://pharmawatchdog.wordpress.com/2012/01/30/fda-finally-addresses-social-networking-issue-gives-guidelines-on-how-to-interact-with-consumers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7890ac322015a6ecd7b4497043175751?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Potts Sadaka LLC</media:title>
		</media:content>
	</item>
		<item>
		<title>Novartis To Pay A Whopping $99 Million In Class Action Lawsuit</title>
		<link>http://pharmawatchdog.wordpress.com/2012/01/30/novartis-to-pay-a-whopping-99-million-in-class-action-lawsuit/</link>
		<comments>http://pharmawatchdog.wordpress.com/2012/01/30/novartis-to-pay-a-whopping-99-million-in-class-action-lawsuit/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 13:00:05 +0000</pubDate>
		<dc:creator>Sadaka Associates</dc:creator>
				<category><![CDATA[Drug Safety News]]></category>
		<category><![CDATA[99 Million]]></category>
		<category><![CDATA[Class Action Lawsuit]]></category>
		<category><![CDATA[Novartis Pharmaceuticals Corp]]></category>
		<category><![CDATA[Settlement]]></category>
		<category><![CDATA[Swiss Drug Maker]]></category>

		<guid isPermaLink="false">http://pharmawatchdog.wordpress.com/?p=632</guid>
		<description><![CDATA[Novartis is getting ready to shell out a lot of dough!  In a recent lawsuit brought by sales representatives who claimed they were denied overtime pay, the plaintiffs won a judge’s preliminary approval of a $99 million settlement. The class-action settlement, tentatively approved on Tuesday, January 24, 2012, by U.S. District Judge Paul Crotty in [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=pharmawatchdog.wordpress.com&amp;blog=1601809&amp;post=632&amp;subd=pharmawatchdog&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://pharmawatchdog.wordpress.com/2012/01/30/novartis-to-pay-a-whopping-99-million-in-class-action-lawsuit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7890ac322015a6ecd7b4497043175751?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Potts Sadaka LLC</media:title>
		</media:content>
	</item>
		<item>
		<title>Johnson &amp; Johnson Suffering From Manufacturing Issues and Recalls</title>
		<link>http://pharmawatchdog.wordpress.com/2012/01/27/johnson-johnson-suffering-from-manufacturing-issues-and-recalls/</link>
		<comments>http://pharmawatchdog.wordpress.com/2012/01/27/johnson-johnson-suffering-from-manufacturing-issues-and-recalls/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 22:00:47 +0000</pubDate>
		<dc:creator>Sadaka Associates</dc:creator>
				<category><![CDATA[Drug Safety News]]></category>
		<category><![CDATA[Medical Device Safety News]]></category>
		<category><![CDATA[Financial Earnings]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Manufacturing Issues]]></category>
		<category><![CDATA[Medical Device]]></category>
		<category><![CDATA[Recalls]]></category>

		<guid isPermaLink="false">http://pharmawatchdog.wordpress.com/?p=629</guid>
		<description><![CDATA[The drug &#38; medical device giant Johnson &#38; Johnson seems to be a name that is coming up a lot lately; from the controversial chemicals found in baby products to the major artificial hip recall surrounding DuPuy Orthopaedic’s, they continually seem to be on the radar. Now, in their just released last quarter financial statement [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=pharmawatchdog.wordpress.com&amp;blog=1601809&amp;post=629&amp;subd=pharmawatchdog&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://pharmawatchdog.wordpress.com/2012/01/27/johnson-johnson-suffering-from-manufacturing-issues-and-recalls/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7890ac322015a6ecd7b4497043175751?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Potts Sadaka LLC</media:title>
		</media:content>
	</item>
	</channel>
</rss>
